Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma

Published:2012-08 Issue:4 Volume:22 Page:287-293
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Hoejberg Lise,Bastholt Lars,Johansen Julia S.,Christensen Ib Jarle,Gehl Julie,Schmidt Henrik

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference39 articles.

1. High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update.;Atkins;Cancer J Sci Am,2000

2. Improving survival in patients with high-risk and metastatic melanoma: immunotherapy leads the way.;Agarwala;Am J Clin Dermatol,2003

3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation.;Chapman;N Engl J Med,2011

4. Improved survival with ipilimumab in patients with metastatic melanoma.;Hodi;N Engl J Med,2010

5. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.;Robert;N Engl J Med,2011

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin modulates purinergic signaling and inflammatory response in cutaneous metastatic melanoma cells;Purinergic Signalling;2024-05-27

2. Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study;Clinical Cancer Research;2024-05-20

3. Immunological Profiles in Mucosal Melanoma with Distinct Prognosis;2024

4. Therapeutic drug monitoring of immune checkpoint inhibitors: based on their pharmacokinetic properties and biomarkers;Cancer Chemotherapy and Pharmacology;2023-07-06

5. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy;Cancer Immunology, Immunotherapy;2023-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3